Is EVOQ Remedies Ltd (543500) a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that EVOQ Remedies Ltd is a below average quality company .

Is EVOQ Remedies Ltd (543500) undervalued or overvalued?

The key valuation ratios of EVOQ Remedies Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone .

What is EVOQ Remedies Ltd (543500) share price return in the past 10 years?

Data is not available for this company

Is EVOQ Remedies Ltd (543500) a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of EVOQ Remedies Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

What is the share price of EVOQ Remedies Ltd (543500)?

Company share prices are keep on changing according to the market conditions. The current trading price of EVOQ Remedies Ltd (543500) on 16-Apr-2026 16:59:59 at 16:59 is 3.39.

What is the P/E ratio of EVOQ Remedies?

The latest standalone P/E ratio of EVOQ Remedies as of 16-Apr-2026 is 95.92.

What is the P/B ratio of EVOQ Remedies Ltd (543500)?

The latest standalone P/B ratio of EVOQ Remedies Ltd (543500) as of 16-Apr-2026 is 0.19.

What is the 52-week high and low of EVOQ Remedies Ltd (543500)?

The 52-week high of EVOQ Remedies Ltd (543500) is Rs. 6.11 and the 52-week low is Rs. 2.27.

EVOQ Remedies Ltd (543500) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: EVOQ Remedies Ltd (543500)
Brand: EVOQ Remedies

EVOQ Remedies Ltd (543500) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹8 Cr.

P/E Ratio

95.92

Price to Book (P/B)

0.19

Price to Sales (P/S)

0.72

EV/EBITDA

46.48

Return on Capital Employed (ROCE)

0.35%

Current Price

₹3.4

Return on Equity (ROE)

0.25%

Return on Assets (ROA)

0.20%

Operating Profit Margin

-19%

Net Profit Margin

0.75%

Gross Profit Margin

1.5%

Book Value per Share

₹17.9

Sales Growth (YoY)

190.37%

Sales Growth (3 Years)

-11.17%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

NAN%

Net Profit Growth (1 Year)

-80%

52-Week Low / High

₹2 / 6

Net Profit Growth (3 Years)

-56.76%

Dividend Yield

0.00%

Promoter Holding

11.21%

Pledged shares (%)
of Promoter's holding (%)

0.00%

Check Before You Invest

Q.1 Revenue growth of EVOQ Remedies Ltd?

EVOQ Remedies Ltd revenue growth is 190.4% for FY-2025 , which is above its 5 year CAGR of 5.3% , indicating faster growth.

Q.1 Promoter shareholding and pledge status of EVOQ Remedies Ltd?

Promoters hold 11.21% of the EVOQ Remedies Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Revenue growth of EVOQ Remedies Ltd vs industry peers?

EVOQ Remedies Ltd revenue CAGR is 5.33% , compared to the industry median CAGR of 0% , indicating faster growth and gaining its market share.

Q.1 Which industry/sub-sector does EVOQ Remedies Ltd belong to?

EVOQ Remedies Ltd belongs to the Miscellaneous sector, operating specifically within the Trading segment.

Q.1 Stock return of EVOQ Remedies Ltd over the last decade?

Over the last 3 year(s), the stock has delivered a CAGR of -37.03% based on the current price.

DeciZen - make an informed investing decision on EVOQ Remedies

Based on:

Data

M-Cap below 100cr DeciZen not available

EVOQ Remedies stock performance

Key Ratios

Is EVOQ Remedies Ltd an attractive stock to invest in?

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	68.9%	2.7%	246.9%	9.1%	7%	1.9%	0.4%	-
Value Creation Index ⓘ	3.9	-0.8	16.6	-0.4	-0.5	-0.9	-1.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	3.3	9.1	10	16.8	20.4	4.1	11.8	12
Sales YoY Gr.	-	179.1%	10.5%	67.5%	21.5%	-80.1%	190.4%	-
Adj EPS ⓘ	0.2	0	10.1	0.8	1.2	0.3	0	0
YoY Gr.	-	-100%	NA	-92.1%	48.8%	-72.3%	-87.9%	-
BVPS (₹) ⓘ	0	0	10.5	17	18.2	18.6	17.9	17.9
Adj Net Profit ⓘ	0	0	0.7	1.1	1.6	0.5	0.1	0
Cash Flow from Ops. ⓘ	0	-0	0	-26.4	-4.4	5.3	-14.6	-
Debt/CF from Ops. ⓘ	0.2	-0.3	0	-0.3	-2.2	0.8	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	5.3%	-11.2%	190.4%
Adj EPS ⓘ	NA	NA	-63.2%	-87.9%
BVPSⓘ	NA	NA	1.7%	-3.6%
Share Price	-	-	-37%	16.5%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	49.8	1.3	186.9	9.1	6.8	1.8	0.3	0.2
Op. Profit Mgn % ⓘ	0.5	0	9.5	8.7	-18.3	-40.4	-19	NAN
Net Profit Mgn % ⓘ	0.3	0	7.1	6.5	7.9	11.2	0.8	0.9
Debt to Equity ⓘ	0.1	0.3	0	0.4	0.4	0.2	0	-
Working Cap Days ⓘ	0	156	249	416	582	3,218	1,340	0
Cash Conv. Cycle ⓘ	0	-34	-38	268	402	1,008	148	0

Recent Performance Summary

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	0	-
TTM Sales (₹ Cr.)	11.8	-
BVPS (₹) ⓘ	17.9	-
Reserves (₹ Cr.) ⓘ	20	-
P/BV ⓘ	0.19	-
PE ⓘ	95.92	-

From the Market
52 Week Low / High (₹)	2.27 / 6.11
All Time Low / High (₹)	2.11 / 25.00
Market Cap (₹ Cr.)	8.4
Equity (₹ Cr.)	24.9
Face Value (₹)	10
Industry PE ⓘ	25.4

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of EVOQ Remedies - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	3.25	9.07	10.02	16.78	20.39	4.05	11.76
Operating Expenses ⓘ +	3.23	9.07	9.07	15.32	24.12	5.69	13.99
Manufacturing Costs	0	0	0.06	0.04	0.09	0.01	0
Material Costs	3.23	9.05	7.85	13.77	19.33	1.56	13.08
Employee Cost	0	0.01	0.01	0.18	0.20	0.08	0.07
Other Costs ⓘ	0.01	0.01	1.15	1.33	4.50	4.04	0.84
Operating Profit ⓘ	0.02	0	0.95	1.46	-3.73	-1.64	-2.24
Operating Profit Margin (%)	0.5%	0.0%	9.5%	8.7%	-18.3%	-40.4%	-19.0%
Other Income ⓘ +	0	0	0	0	6.02	2.26	2.41
Exceptional Items ⓘ	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0
Depreciation ⓘ	0	0	0	0	0	0.01	0.05
Profit Before Tax ⓘ	0.02	0	0.95	1.46	2.28	0.61	0.13
Tax ⓘ	0	0	0.24	0.37	0.67	0.16	0.04
Profit After Tax	0.01	0	0.72	1.09	1.62	0.45	0.09
PAT Margin (%)	0.3%	0.0%	7.1%	6.5%	7.9%	11.2%	0.8%
Adjusted EPS (₹)	0.2	0.0	10.1	0.8	1.2	0.3	0.0
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	0.02	0.02	0.74	23.17	24.79	25.24	44.54
Share Capital ⓘ	0.01	0.01	0.01	13.60	13.60	13.60	24.90
Reserves ⓘ	0.01	0.01	0.73	9.57	11.19	11.64	19.64
Debt +	0	0.01	0	8.16	9.58	4.24	0
Long Term Debt	0	0.01	0	0	0	0	0
Short Term Debt	0	0	0	8.16	9.58	4.24	0
Minority Interest	0	0	0	0	0	0	0
Trade Payables	2.12	5.62	6.78	1.21	-0.54	3.28	3.50
Others Liabilities ⓘ	0.01	0	0.52	0.80	1.07	4.10	1.98
Total Liabilities ⓘ	2.15	5.65	8.05	33.33	34.90	36.86	50.01
Fixed Assets
Net Fixed Assets ⓘ +	0	0	0	0	0.01	0.01	0.22
Gross Block	0	0	0	0	0.01	0.01	0.22
Accumulated Depreciation	0	0	0	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0
Inventories	0.03	0.06	0.15	0.78	2.03	3.13	2.22
Trade Receivables	1.23	4.72	6.84	25.40	17.22	1.74	8.62
Cash Equivalents	0.02	0	0.03	3.09	0.15	0.12	0.21
Others Assets ⓘ	0.87	0.87	1.03	4.06	15.49	31.86	38.74
Total Assets ⓘ	2.15	5.65	8.05	33.33	34.90	36.86	50.01

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.01	-0.02	0.03	-26.43	-4.35	5.32	-14.62
PBT ⓘ	0.02	0	0.72	1.46	2.28	0.61	0.13
Adjustment ⓘ	0	0	0	0	0.01	0.01	0.05
Changes in Working Capital ⓘ	-0	-0.02	-0.68	-27.52	-5.97	4.86	-14.76
Tax Paid ⓘ	-0	-0	0	-0.37	-0.67	-0.16	-0.04
Cash Flow From Investing Activity ⓘ +	0	0	0	0	-0.01	-0.01	-0.26
Capex	0	0	0	0	-0.01	-0.01	-0.26
Net Investments	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	0	0	0	29.49	1.42	-5.34	14.97
Net Proceeds from Shares ⓘ	0	0	0	21.33	0	0	19.21
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0
Others ⓘ	0	0	0	8.16	1.42	-5.34	-4.24
Net Cash Flow ⓘ	0.01	-0.02	0.03	3.06	-2.94	-0.03	0.09

Finance Ratio

PARTICULARS	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	49.78	1.34	186.89	9.13	6.75	1.81	0.25
ROCE (%)	68.94	2.69	246.9	9.12	6.96	1.92	0.35
Asset Turnover Ratio	1.51	2.33	1.46	0.81	0.6	0.11	0.27
PAT to CFO Conversion(x)	1	N/A	0.04	-24.25	-2.69	11.82	-162.44
Working Capital Days
Receivable Days	138	120	210	351	381	854	161
Inventory Days	3	2	4	10	25	232	83
Payable Days	240	156	288	106	6	322	95

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

EVOQ Remedies Ltd FAQs

The current trading price of EVOQ Remedies on 16-Apr-2026 16:59 is ₹3.39.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 15-Apr-2026 the market cap of EVOQ Remedies stood at ₹8.44 Cr

The latest P/E ratio of EVOQ Remedies as of 15-Apr-2026 is 95.92.

The latest P/B ratio of EVOQ Remedies as of 15-Apr-2026 is 0.19.

The 52-week high of EVOQ Remedies is ₹6.11 and the 52-week low is ₹2.27.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of EVOQ Remedies is ₹11.76 ( Cr.) .

About EVOQ Remedies Ltd

EVOQ Remedies is one of the recognized trading house of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs at affordable price catering to the customers located in Ahmedabad. It procures the pharmaceuticals Raw Materials products and chemicals from the suppliers which are having WHO-GMP approved production facilities in India and by focusing on its first-class distribution expertise.

In the area of Pharmaceuticals Raw Materials, Excipients, Bulk Drugs etc., the company is specializes in offering quality products and affordable trading in Gujarat. The company has a team of focused industry experts, who have in-depth knowledge of the industry and have with them expertise in offering best solutions for meeting their specific needs. It procure all the products from certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards. In order to achieve the task, it keep its regular visit to ensure quality and reliability of the products. Keeping its basic objective in mind, it strive hard to exceed all the expectations of its clients by supplying best quality products at the most reasonable prices. EVOQ is having its registered office, corporate office and storage location facilities located in Ahmedabad. In the healthcare segment, EVOQ being into trading business offers a wide basket of products.

EVOQ majorly does trading in following segments of pharmaceuticals raw materials:

Excipients
Nutraceuticals
Pellets
Solvents
Sweetners
Vitamins
Amino Acids
Bulk Drugs
Dairy Products
Active Pharmaceuticals Ingredients

Business area of the company

The company specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices.

Major events:

2010: Incorporation of Company as ‘Salus Life Science and Research Private Limited’ at Ahmedabad, Gujarat on February 24th, 2010 under the provisions of the Companies Act, 1956.
2021: Conversion of the Company into public limited company, the name of the company was changed to ‘Evoq Remedies Limited’ and fresh Certificate of Incorporation dated July 28, 2021 was issued by Registrar of Companies, Ahmedabad.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

EVOQ Remedies Ltd (543500) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

EVOQ Remedies Share Price